Fate Therapeutics Inc. – Underwriting Agreements

NASDAQ: FATE
Share price (5/22/26): $2.25
Market cap (5/22/26): $262 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Underwriting Agreements Filter

from 8-K 43 pages Fate Therapeutics, Inc. (A Delaware Corporation) 14,545,454 Shares of Common Stock Underwriting Agreement

from S-3 43 pages Open Market Sale Agreementsm

from S-3ASR 41 pages Open Market Sale Agreementsm

from 8-K 41 pages Open Market Sale Agreementsm

from 8-K 50 pages 4,421,053 Shares and Pre-Funded Warrants to Purchase 257,310 Shares Fate Therapeutics, Inc. Underwriting Agreement

from 8-K 50 pages 6,181,562 Shares Fate Therapeutics, Inc. Underwriting Agreement

from 8-K 49 pages 8,600,000 Shares Fate Therapeutics, Inc. Underwriting Agreement

from S-3ASR 44 pages Fate Therapeutics, Inc. Shares of Common Stock ($0.001 Par Value Per Share) Sales Agreement

from 8-K 44 pages Fate Therapeutics, Inc. Shares of Common Stock ($0.001 Par Value Per Share) Sales Agreement

from 8-K 48 pages 9,259,260 Shares Fate Therapeutics, Inc. Underwriting Agreement

from 8-K 32 pages 9,525,000 Shares Fate Therapeutics, Inc. Common Stock, Par Value $0.001 Per Share Underwriting Agreement December 12, 2017

from 8-K 34 pages 6,000,000 Shares Fate Therapeutics, Inc. Common Stock, Par Value $0.001 Per Share Underwriting Agreement May 20, 2015

from S-1/A 38 pages [ ] Shares Fate Therapeutics, Inc. Common Stock Underwriting Agreement